Citigroup’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,000
Closed -$4.14M 5819
2023
Q4
$4.14M Buy
+23,000
New +$3.58M ﹤0.01% 1717

Other funds holding RGEN

Citigroup's RGEN Position: Q1 2026 in Review

Citigroup reduced its Repligen (RGEN) stake by 57% in Q1 2026, selling an estimated $6.62M and leaving 36,356 shares worth $4.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2086.

Citigroup first reported a position in RGEN in Q2 2013 and has held it in 52 quarters since. The position peaked at $13.9M in Q3 2024. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Citigroup held 36,356 shares of Repligen worth $4.28M as of Q1 2026.
  • Citigroup sold 47,396 Repligen shares in Q1 2026, an estimated $6.62M.
  • Repligen made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2086 holding.
  • Citigroup first reported a position in Repligen in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's Repligen position peaked at $13.9M in Q3 2024.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.